1. Home
  2. TYGO vs MSLE Comparison

TYGO vs MSLE Comparison

Compare TYGO & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tigo Energy Inc.

TYGO

Tigo Energy Inc.

HOLD

Current Price

$2.06

Market Cap

129.0M

Sector

Technology

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$10.03

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TYGO
MSLE
Founded
2007
N/A
Country
United States
Canada
Employees
N/A
21
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
129.0M
154.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYGO
MSLE
Price
$2.06
$10.03
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
1.2M
87.7K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
97.12
N/A
EPS
N/A
N/A
Revenue
$103,536,000.00
N/A
Revenue This Year
$30.78
N/A
Revenue Next Year
$21.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
91.68
N/A
52 Week Low
$1.21
$5.44
52 Week High
$5.33
$13.39

Technical Indicators

Market Signals
Indicator
TYGO
MSLE
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TYGO
MSLE

About TYGO Tigo Energy Inc.

Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: